Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Nanoparticle albumin-bound paclitaxel

EU orphan designation number: EU/3/10/809
Active ingredient: Nanoparticle albumin-bound paclitaxel
Indication: Treatment of pancreatic cancer
Sponsor: Celgene Europe Limited
1 Longwalk Road, Stockley Park, Uxbridge, Middlesex UB11 1DB, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
1/12/2010 Orphan designation EMA/OD/087/10 (2010)8594 of 26/11/2010
1/09/2011 Transfer of orphan designation EMA/OD/087/10/T/01 (2011)6291 of 30/08/2011
7/02/2013 Removal of orphan designation from Community Register